Last Updated: May 10, 2026

Suppliers and packagers for kyzatrex


✉ Email this page to a colleague

« Back to Dashboard


kyzatrex

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Marius KYZATREX testosterone undecanoate CAPSULE;ORAL 213953 NDA Marius Pharmaceuticals 80603-103-11 90 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-103-11) 2022-07-27
Marius KYZATREX testosterone undecanoate CAPSULE;ORAL 213953 NDA Marius Pharmaceuticals 80603-103-22 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-103-22) 2022-07-27
Marius KYZATREX testosterone undecanoate CAPSULE;ORAL 213953 NDA Marius Pharmaceuticals 80603-105-11 90 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-105-11) 2022-07-27
Marius KYZATREX testosterone undecanoate CAPSULE;ORAL 213953 NDA Marius Pharmaceuticals 80603-105-22 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-105-22) 2022-07-27
Marius KYZATREX testosterone undecanoate CAPSULE;ORAL 213953 NDA Marius Pharmaceuticals 80603-105-33 60 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-105-33) 2022-07-27
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for kyzatrex

Last updated: April 26, 2026

Who Supplies the Inputs for Kyzatrex?

What companies supply Kyzatrex materials?

No reliable, citable sourcing data is available to identify manufacturers, API suppliers, intermediates suppliers, fill-finish partners, or packaging providers for Kyzatrex based on patent records, regulatory filings, or published supplier disclosures that can be cited.

What supply chain roles are typically identifiable in patents for a drug like Kyzatrex?

When supply-chain identification is supported by citable records, the usual patent and regulatory trace points fall into these buckets:

  • API / Drug substance: named chemical manufacturers and intermediate makers in prosecution history, examples, or manufacturing sections.
  • Intermediates: salts, key building blocks, catalysts, and purification reagents tied to synthetic routes.
  • Drug product: tablets/capsules formulation sites, sterile fill-finish for injectables, and stability program vendors.
  • Packaging and devices: bottle, blister, carton, and delivery device components named in marketing authorization dossiers or labeling.

For Kyzatrex, none of these supplier names can be extracted with citation-grade certainty from the information provided.

How does Kyzatrex supplier identification usually work in practice (patent lens)?

In practice, a supplier map is built by linking:

  • Grant and application families to the assignee and named inventors who often correspond to internal manufacturing or contracted CDMOs.
  • Manufacturing examples to specific raw materials and vendors that are named in the record.
  • Regional marketing authorization documents to manufacturing sites and release testing locations.
  • Quality and control sections to excipient suppliers only when explicitly disclosed.

No citable Kyzatrex-specific record is available here to execute that linkage.

What can be concluded about Kyzatrex suppliers from the available data?

Nothing actionable can be concluded about which firms supply Kyzatrex inputs, because no supplier list or manufacturing-site disclosure can be cited for Kyzatrex from the material in this request.

Key Takeaways

  • No citation-grade supplier roster for Kyzatrex can be produced from the information available.
  • Patent and regulatory supplier identification requires drug-specific records (assignee-linked manufacturing sites, examples naming vendors, or dossier manufacturing sections), which are not present here.
  • Any named supplier list without citable support would not meet an evidence standard for R&D or investment decision-making.

FAQs

  1. Can you list the API manufacturer for Kyzatrex?
    No citable API manufacturer information is available in the provided context.

  2. Can you identify Kyzatrex intermediates suppliers?
    No citable intermediate supplier information is available in the provided context.

  3. Can you identify the CDMO or fill-finish site for Kyzatrex drug product?
    No citable drug-product manufacturing-site information is available in the provided context.

  4. Can you list excipient and packaging suppliers for Kyzatrex?
    No citable excipient or packaging supplier information is available in the provided context.

  5. Can you map Kyzatrex suppliers by country or region?
    No citable regional manufacturing disclosures are available in the provided context.

References

[1] No sources were provided in the request, and no citable Kyzatrex supplier records are available in the provided material.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.